Full Course Description

Fall Prevention Challenges: Real Solutions to Reduce Falls, Prevent Injuries and Limit Liability

Program Information

Outline

How to Prevent Falls Before They Occur

  • Who is likely to fall?
  • Which risk factors can we modify?
  • Precipitating causes - what to watch for
  • Institutional barriers - avoiding 1:1s
  • Important implications of co-morbidities
  • The benefits of vitamin D

Fall Risk Assessment

  • Current guidelines
  • Who should we screen?
  • Multi-factorial causes of falls
  • Recommended fall risk assessments

Fall Prevention Strategies

  • What works and what does not
  • Addressing alarm fatigue
  • Avoiding 1:1s
  • Effective evidence-based interventions
  • Education & assistive devices

Putting Together a Successful Fall Prevention Program

  • Patient-specific interventions
  • Developing a multidisciplinary program: Roles & responsibilities
  • Fall rounds

Patient Evaluation

  • History
  • Physical exam
  • Evaluation tools (POMA tool, Get up and go test, Functional reach test, Berg balance test, Short physical performance battery)
  • Diagnostic tests
  • Review of Gait Disorders (video)

What to do When a Patient Falls: Hands-On Evaluation

  • Assess need for immediate medical care
  • Evaluate for acute illness/preceding factors
  • Communication with caregivers
  • Common injuries
  • Goals of care

Difficult Situations

  • Frequent fallers - when injury prevention is your goal!
  • Anticoagulation risks
  • Prolonged time on floor
  • What to do when fractures occur
  • Head trauma management

Preventing Risk and Limiting Liability

  • Home safety evaluations
  • Communication and documentation
  • Quality improvement opportunities
  • High-risk scenarios: Case studies
  • Addressing family concerns with falls
  • Managing poor outcomes

Fall Prevention Plan Development

  • Apply what we have learned
  • Solutions for your biggest challenges!

Objectives

  1. Evaluate precipitating causes for falls so that preventative measures can be in place.
  2. Formulate a comprehensive evaluation for high fall risk patients.
  3. Analyze medications that are known to contribute in various ways to fall risks.
  4. Assess the risk for adverse patient outcome and need for urgent intervention.
  5. Determine the tools necessary for a multidisciplinary fall prevention program.
  6. Select patient-specific fall prevention interventions for a successful fall prevention plan.
  7. Evaluate the impact of common gait disorders on fall risk.

 

Target Audience

Nurses, Nursing Home Administrators, Occupational Therapists & Occupational Therapy Assistants, Physical Therapists/Physical Therapist Assistants, and other Healthcare Professionals

Copyright : 11/16/2016

Infection Control Challenges: Real Risks for Patients and Staff

OUTLINE

A summary of current recommendations from the CDC, SHEA, IDSA, APIC and the Joint Commission

Health-Care Associated Infections: Strategies to Control-Reduce-Eliminate

Program Information

Outline

National Healthcare Safety Network

  • New requirements from CMS
  • Health-care Associated Infections what to report to the CDC

Compendium Strategies: Critical Updates

  • Catheter-Associated Urinary Tract Infections
  • Surgical Site Infections
  • Ventilator Associated Pneumonias
  • Central-Line Associated Bloodstream Infections
  • Influenza Outbreaks in Healthcare

CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms

  • CRE: Carbapenem-Resistant Enterobacteriaceae
    • The Nightmare Bug
    • “Very” Resistant-Dangerous Klebisella and E. Coli
    • Death rate of 50-60%
  • C Diff: Clostridium Difficule
    • Epidemiology
    • New Treatments-cure 90%
      • Microbiota
  • MRSA: Methicillin-Resistant Staphlococcus Aureus
    • Community or Healthcare Associated
    • Decolonization of MRSA
  • VRE: Vancomycin Resistant Enterococcus
    • Daptomycin Resistant Enterococcus
  • ESBL:  Extended Spectrum Beta-Lactamase Organisms
    • Resistant Klebisella and E. Coli

EBOLA: What’s New, What’s True & What’s Next

  • Probable Reservoir & Epizootic Cycle
    • Bats
    • Non-Human Primates
    • Duikers
  • Prior Outbreaks of Ebola in Africa
    • Sudan (1976 & 1979 & 2005)
    • Kikwit, Congo (1995)
    • Gabon (1994-1996)
    • Uganda (2000-2001 & 2007-2008)
    • DRC (2007)
  • Symptoms of Ebola
    • Fever
    • Myalgia
    • Malaise
    • Vomiting/Diarrhea
    • Abdominal Pain
    • Unexplained Hemorrhage
  • Transmission of Ebola
    • Bodily Fluids
    • Cultural Rituals
  • Possible Treatments for Ebola
    • Supportive
    • Mono-clonal Antibodies 
  • Appropriate Infection Control Protocols
    • PPEs
    • During Aerosol-Generating Procedures
    • Hand-washing and Disinfectants 
  • Appropriate laboratory tests
    • EIA-ELISA
    • PCR
    • IgM
  • Protocol for Testing for Ebola
    • Appropriate Risks
    • CDC (Centers for Disease Control)

Emerging Infectious Diseases: Exotic to the Common

  • Meningococcal Disease
    • Bacterial, Fungal & Viral Meningitis
    • New Vaccines for Serogroup B
    • Could be a disease of the past
  • Dengue Fever and Chikungunya
    • New threat to USA
  • Tickborne Diseases
    • Lyme
    • Ehrichioses
    • Babesiosis
    • Rocky Mountain Spotted Fever

Managing Foodborne Illnesses

  • E. Coli O157-H7
  • Salmonella
  • Listeria
  • Campylobacter
  • Vibrio
  • Norovirus

Vaccine Preventable Diseases are Back!

  • Pertussis (Whooping cough)
  • Measles
  • Controlling Outbreaks

Influenza Information

  • Current Vaccine
  • Treatments
  • Prophylaxis
  • Infection Control Protocols
  • Seasonal vs Pandemics (H1N1)

Pneumococcal Disease

  • New Vaccine for Adults
  • New Protocols
  • PPSV-23 & PCV-13
    • Need both if ≥ 65 years

Updates & New Protocols for Bloodborne Pathogens

  • Hepatitis B:
    • Protocols for Immunizations
      • Healthcare Personnel
      • Children-Adolescents
      • Diabetics
    • Approved Treatments for Chronic Hepatitis B
    • Outbreaks of Hepatitis B and C in Healthcare
  • Hepatitis C:
    • Risk Groups and Factors
    • New Treatment
      • No more Interferon
    • One pill for 12 weeks
    • 95-100% Cure Rate
  • HIV/AIDS:
    • “Now a Confirmed Cured Patient”
      • The Science Behind the Cure
    • New Treatment: One Pill a Day
    • Prophylaxis for High Risk Groups
    • The Strategy to Eradicate HIV-AIDS
  • Tuberculosis:
    • Blood Test vs Skin Testing
      • IGRA (Interferon Gamma Release Assays)
    • New Treatment Protocols
      • New Prophylaxis Regimen
      • Three Months vs Nine Months
    • Infection Control Protocols for TB

 

Objectives

  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.

Target Audience

Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Respiratory Therapists

Copyright : 10/13/2016

Program Information

Objectives

  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.

Program Information

Objectives

  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.